These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4146776

  • 1. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.
    Yamada K, Shimamura T, Nakajima H.
    Jpn J Pharmacol; 1973 Jun; 23(3):321-8. PubMed ID: 4146776
    [No Abstract] [Full Text] [Related]

  • 2. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T, Eckfeld DK, Shropshire AT, Rowles G, Varner LL.
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract] [Full Text] [Related]

  • 3. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT, Spann JF, Zelis R, Amsterdam EA.
    Clin Pharmacol Ther; 1970 Sep; 11(4):460-80. PubMed ID: 4913865
    [No Abstract] [Full Text] [Related]

  • 4. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T, Rowles G, Shropshire AT.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K, Oshima T, Koike H.
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR, Hanna C.
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
    Nakayama K, Oshima T, Kumakura S, Hashimoto K.
    Eur J Pharmacol; 1971 May; 14(1):9-18. PubMed ID: 4396662
    [No Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C, Schmid JR.
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract] [Full Text] [Related]

  • 9. [Antiarrhythmic action of penbutolol].
    Boissier JR, Coutte R, Bertin MC, Giudicelli JF.
    Therapie; 1974 Jun; 29(2):261-9. PubMed ID: 4152641
    [No Abstract] [Full Text] [Related]

  • 10. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF, Witchitz S, Larno S, Boissier JR.
    Biomedicine; 1973 Jul 20; 19(7):308-13. PubMed ID: 4783987
    [No Abstract] [Full Text] [Related]

  • 11. The antiarrhythmic properties of BL-3677A.
    Buyniski JP, Gardier RW.
    J Pharmacol Exp Ther; 1974 Aug 20; 190(2):289-99. PubMed ID: 4449041
    [No Abstract] [Full Text] [Related]

  • 12. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M, Cheymol G, Mouillé P, Gilbert JC, Schmitt H.
    Arch Int Pharmacodyn Ther; 1973 Feb 20; 201(2):323-33. PubMed ID: 4146788
    [No Abstract] [Full Text] [Related]

  • 13. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M, Imamura H, Nakamura T.
    Nihon Yakurigaku Zasshi; 1972 Mar 20; 68(2):240-53. PubMed ID: 4403394
    [No Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ, Thomsen P, Raap A.
    Ann N Y Acad Sci; 1995 Jul 12; 763():620-33. PubMed ID: 7677382
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacological treatment of arrhythmia].
    Kuch J.
    Pol Tyg Lek; 1983 Jan 17; 38(3):103-8. PubMed ID: 6135199
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B, Jordan R, Loveless AH, Maxwell DR.
    Br J Pharmacol; 1974 Mar 17; 50(3):323-33. PubMed ID: 4850183
    [Abstract] [Full Text] [Related]

  • 17. Drugs and the heart. IV. Antiarrhythmic agents.
    Opie LH.
    Lancet; 1980 Apr 19; 1(8173):861-8. PubMed ID: 6103220
    [No Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H, Noguchi Y, Takagi K.
    Jpn J Pharmacol; 1974 Aug 19; 24(4):589-9. PubMed ID: 4455968
    [No Abstract] [Full Text] [Related]

  • 19. Experimental anti-arrhythmic properties of melperone, a neuroleptic butyrophenone.
    Petersen EN.
    Acta Pharmacol Toxicol (Copenh); 1978 May 19; 42(5):388-94. PubMed ID: 581034
    [Abstract] [Full Text] [Related]

  • 20. [Antiarrhythmic effect of blocking agent of beta-adrenergic receptors napriline].
    Gorodinskaia VIa.
    Farmakol Toksikol; 1969 May 19; 32(1):43-7. PubMed ID: 5770314
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.